Advertisement
Mayo Clinic Proceedings Home

Relationship of Body Mass Index With Total Mortality, Cardiovascular Mortality, and Myocardial Infarction After Coronary Revascularization: Evidence From a Meta-analysis

      Abstract

      Objective

      To investigate the relationship of body mass index (BMI) with total mortality, cardiovascular (CV) mortality, and myocardial infarction (MI) after coronary revascularization procedures (coronary artery bypass grafting [CABG] and percutaneous coronary intervention [PCI]).

      Patients and Methods

      Systematic search of studies was conducted using PubMed, CINAHL, Cochran CENTRAL, Scopus, and the Web of Science databases. We identified studies reporting the rate of MI, CV mortality, and total mortality among coronary artery disease patients' postcoronary revascularization procedures in various BMI categories: less than 20 (underweight), 20-24.9 (normal reference), 25-29.9 (overweight), 30-34.9 (obese), and 35 or more (severely obese). Event rates were compared using a random effects model assuming interstudy heterogeneity.

      Results

      A total of 36 studies (12 CABG; 26 PCI) were selected for final analyses. The risk of total mortality (relative risk [RR], 2.59; 95% CI, 2.09-3.21), CV mortality (RR, 2.67; 95% CI, 1.63-4.39), and MI (RR, 1.79; 95% CI, 1.28-2.50) was highest among patients with low BMI at the end of a mean follow-up period of 1.7 years. The risk of CV mortality was lowest among overweight patients (RR, 0.81; 95% CI, 0.68-0.95). Increasing degree of adiposity as assessed by BMI had a neutral effect on the risk of MI for overweight (RR, 0.92; 95% CI, 0.84-1.01), obese (RR, 0.99; 95% CI, 0.85-1.15), and severely obese (RR, 0.93; 95% CI, 0.78-1.11) patients.

      Conclusion

      After coronary artery disease revascularization procedures (PCI and CABG), the risk of total mortality, CV mortality, and MI was highest among underweight patients as defined by low BMI and CV mortality was lowest among overweight patients.

      Abbreviations and Acronyms:

      BMI (body mass index), CABG (coronary artery bypass graft), CAD (coronary artery disease), CV (cardiovascular), CVD (cardiovascular disease), MOOSE (Meta-Analysis of Observational Studies in Epidemiology), PCI (percutaneous coronary intervention), WC (waist circumference), WHR (waist-hip ratio)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Poirier P.
        • Giles T.D.
        • Bray G.A.
        • et al.
        • American Heart Association; Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism
        Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism.
        Circulation. 2006; 113: 898-918
        • Hedley A.A.
        • Ogden C.L.
        • Johnson C.L.
        • Carroll M.D.
        • Curtin L.R.
        • Flegal K.M.
        Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.
        JAMA. 2004; 291: 2847-2850
        • Whitlock G.
        • Lewington S.
        • et al.
        • Prospective Studies Collaboration
        Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies.
        Lancet. 2009; 373: 1083-1096
        • Flegal K.M.
        • Carroll M.D.
        • Kit B.K.
        • Ogden C.L.
        Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010.
        JAMA. 2012; 307: 491-497
        • Garrison R.J.
        • Castelli W.P.
        Weight and thirty-year mortality of men in the Framingham Study.
        Ann Intern Med. 1985; 103: 1006-1009
        • Rabkin S.W.
        • Mathewson F.A.
        • Hsu P.H.
        Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study.
        Am J Cardiol. 1977; 39: 452-458
        • Minutello R.M.
        • Chou E.T.
        • Hong M.K.
        • et al.
        Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry).
        Am J Cardiol. 2004; 93: 1229-1232
        • Parsonnet V.
        • Dean D.
        • Bernstein A.D.
        A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease.
        Circulation. 1989; 79: I3-I12
        • Eagle K.A.
        • Guyton R.A.
        • Davidoff R.
        • et al.
        ACC/AHA guidelines for coronary artery bypass graft surgery: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1991 guidelines for coronary artery bypass graft surgery).
        Circulation. 1999; 100: 1464-1480
        • Prabhakar G.
        • Haan C.K.
        • Peterson E.D.
        • Coombs L.P.
        • Cruzzavala J.L.
        • Murray G.F.
        The risks of moderate and extreme obesity for coronary artery bypass grafting outcomes: a study from the Society of Thoracic Surgeons' database.
        Ann Thorac Surg. 2002; 74 (discussion 1130-1131): 1125-1130
        • Gurm H.S.
        • Brennan D.M.
        • Booth J.
        • Tcheng J.E.
        • Lincoff A.M.
        • Topol E.J.
        Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox).
        Am J Cardiol. 2002; 90: 42-45
        • Khattab A.A.
        • Daemen J.
        • Richardt G.
        • et al.
        Impact of body mass index on the one-year clinical outcome of patients undergoing multivessel revascularization with sirolimus-eluting stents (from the Arterial Revascularization Therapies Study Part II).
        Am J Cardiol. 2008; 101: 1550-1559
        • Gurm H.S.
        • Whitlow P.L.
        • Kip K.E.
        • BARI Investigators
        The impact of body mass index on short- and long-term outcomes in patients undergoing coronary revascularization: insights from the bypass angioplasty revascularization investigation (BARI).
        J Am Coll Cardiol. 2002; 39: 834-840
        • Gruberg L.
        • Weissman N.J.
        • Waksman R.
        • et al.
        The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox?.
        J Am Coll Cardiol. 2002; 39: 578-584
        • Stroup D.F.
        • Berlin J.A.
        • Morton S.C.
        • et al.
        Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.
        JAMA. 2000; 283: 2008-2012
        • Gruberg L.
        • Mercado N.
        • Milo S.
        • et al.
        Impact of body mass index on the outcome of patients with multivessel disease randomized to either coronary artery bypass grafting or stenting in the ARTS trial: The obesity paradox II?.
        Am J Cardiol. 2005; 95: 439-444
        • Younge J.O.
        • Damen N.L.
        • van Domburg R.T.
        • Pedersen S.S.
        Obesity, health status, and 7-year mortality in percutaneous coronary intervention: in search of an explanation for the obesity paradox.
        Int J Cardiol. 2013; 167: 1154-1158
        • Nikolsky E.
        • Stone G.W.
        • Grines C.L.
        • et al.
        Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction.
        Am Heart J. 2006; 151: 168-175
        • Powell B.D.
        • Lennon R.J.
        • Lerman A.
        • et al.
        Association of body mass index with outcome after percutaneous coronary intervention.
        Am J Cardiol. 2003; 91: 472-476
        • Kosuge M.
        • Kimura K.
        • Kojima S.
        • et al.
        Impact of body mass index on in-hospital outcomes after percutaneous coronary intervention for ST segment elevation acute myocardial infarction.
        Circ J. 2008; 72: 521-525
        • Mehta L.
        • Devlin W.
        • McCullough P.A.
        • et al.
        Impact of body mass index on outcomes after percutaneous coronary intervention in patients with acute myocardial infarction.
        Am J Cardiol. 2007; 99: 906-910
        • Poston W.S.
        • Haddock C.K.
        • Conard M.
        • Spertus J.A.
        Impact of obesity on disease-specific health status after percutaneous coronary intervention in coronary disease patients.
        Int J Obes Relat Metab Disord. 2004; 28: 1011-1017
        • Johnston J.
        • Bourassa M.
        • Vlachos H.
        • et al.
        The impact of body weight on outcome after percutaneous coronary intervention — The obesity paradox revisited: A report from the National, Heart, Lung, and Blood Institute Dynamic Registry.
        J Am Coll Cardiol. 2003; 41: 47-48
        • Kang W.Y.
        • Jeong M.H.
        • Ahn Y.K.
        • et al.
        Obesity paradox in Korean patients undergoing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction.
        J Cardiol. 2010; 55: 84-91
        • Ellis S.G.
        • Elliott J.
        • Horrigan M.
        • Raymond R.E.
        • Howell G.
        Low-normal or excessive body mass index: newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention.
        Am J Cardiol. 1996; 78: 642-646
        • Nikolsky E.
        • Kosinski E.
        • Mishkel G.J.
        • et al.
        Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial).
        Am J Cardiol. 2005; 95: 709-715
        • Sarno G.
        • Garg S.
        • Onuma Y.
        • et al.
        The impact of body mass index on the one year outcomes of patients treated by percutaneous coronary intervention with Biolimus- and Sirolimus-eluting stents (from the LEADERS Trial).
        Am J Cardiol. 2010; 105: 475-479
        • Sarno G.
        • Räber L.
        • Onuma Y.
        • et al.
        Impact of body mass index on the five-year outcome of patients having percutaneous coronary interventions with drug-eluting stents.
        Am J Cardiol. 2011; 108: 195-201
        • Akin I.
        • Tölg R.
        • Hochadel M.
        • et al.
        No evidence of “obesity paradox” after treatment with drug-eluting stents in a routine clinical practice: results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) Registry.
        JACC Cardiovasc Interv. 2012; 5: 162-169
        • Kaneko H.
        • Yajima J.
        • Oikawa Y.
        • et al.
        Obesity paradox in Japanese patients after percutaneous coronary intervention: an observation cohort study.
        J Cardiol. 2013; 62: 18-24
        • Iakobishvili Z.
        • Danicek V.
        • Porter A.
        • Assali A.R.
        • Battler A.
        • Hasdai D.
        Is increased body mass index associated with a cardioprotective effect after ST-segment-elevation myocardial infarction?.
        Acute Card Care. 2006; 8: 95-98
        • Shubair M.M.
        • Prabhakaran P.
        • Pavlova V.
        • Velianou J.L.
        • Sharma A.M.
        • Natarajan M.K.
        The relationship of body mass index to outcomes after percutaneous coronary intervention.
        J Interv Cardiol. 2006; 19: 388-395
        • Mehta R.H.
        • Gitt A.K.
        • Jünger C.
        • et al.
        Body mass index and effectiveness of reperfusion strategies: implications for the management of patients with ST-elevation myocardial infarction.
        J Interv Cardiol. 2008; 21: 8-14
        • Poludasu S.
        • Cavusoglu E.
        • Khan W.
        • Marmur J.D.
        Impact of body mass index on long-term all-cause mortality after percutaneous coronary intervention in African-Americans.
        J Invasive Cardiol. 2009; 21: 20-25
        • Lancefield T.
        • Clark D.J.
        • Andrianopoulos N.
        • et al.
        Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry.
        JACC Cardiovasc Interv. 2010; 3: 660-668
        • Wang Z.J.
        • Zhao Y.X.
        • Liu Y.Y.
        • et al.
        Sex difference in the effect of obesity on prognosis for patients undergoing percutaneous coronary intervention.
        Coron Artery Dis. 2012; 23: 404-411
        • Engel A.M.
        • McDonough S.
        • Smith J.M.
        Does an obese body mass index affect hospital outcomes after coronary artery bypass graft surgery?.
        Ann Thorac Surg. 2009; 88: 1793-1800
        • Kim J.
        • Hammar N.
        • Jakobsson K.
        • Luepker R.V.
        • McGovern P.G.
        • Ivert T.
        Obesity and the risk of early and late mortality after coronary artery bypass graft surgery.
        Am Heart J. 2003; 146: 555-560
        • Pan W.
        • Hindler K.
        • Lee V.V.
        • Vaughn W.K.
        • Collard C.D.
        Obesity in diabetic patients undergoing coronary artery bypass graft surgery is associated with increased postoperative morbidity.
        Anesthesiology. 2006; 104: 441-447
        • Rapp-Kesek D.
        • Ståhle E.
        • Karlsson T.T.
        Body mass index and albumin in the preoperative evaluation of cardiac surgery patients.
        Clin Nutr. 2004; 23: 1398-1404
        • Ennker J.
        • Schoeneich R.
        • Schröder T.
        • Schoeneich F.
        • Ennker I.C.
        The impact of morbid obesity on the peri- and postoperative course after aortocoronary bypass surgery.
        Dtsch Med Wochenschr. 2001; 126 ([in German]): 419-423
        • Reeves B.C.
        • Ascione R.
        • Chamberlain M.H.
        • Angelini G.D.
        Effect of body mass index on early outcomes in patients undergoing coronary artery bypass surgery.
        J Am Coll Cardiol. 2003; 42: 668-676
        • Jin R.
        • Grunkemeier G.L.
        • Furnary A.P.
        • Handy Jr., J.R.
        Is obesity a risk factor for mortality in coronary artery bypass surgery?.
        Circulation. 2005; 111: 3359-3365
        • Bhamidipati C.M.
        • LaPar D.J.
        • Mehta G.S.
        • et al.
        Albumin is a better predictor of outcomes than body mass index following coronary artery bypass grafting.
        Surgery. 2011; 150: 626-634
        • Le-Bert G.
        • Santana O.
        • Pineda A.M.
        • Zamora C.
        • Lamas G.A.
        • Lamelas J.
        The obesity paradox in elderly obese patients undergoing coronary artery bypass surgery.
        Interact Cardiovasc Thorac Surg. 2011; 13: 124-127
        • Rahmanian P.B.
        • Adams D.H.
        • Castillo J.G.
        • Chikwe J.
        • Bodian C.A.
        • Filsoufi F.
        Impact of body mass index on early outcome and late survival in patients undergoing coronary artery bypass grafting or valve surgery or both.
        Am J Cardiol. 2007; 100: 1702-1708
        • Suwaidi J.A.
        • Wright R.S.
        • Grill J.P.
        • et al.
        Obesity is associated with premature occurrence of acute myocardial infarction.
        Clin Cardiol. 2001; 24: 542-547
        • Rubinshtein R.
        • Halon D.A.
        • Jaffe R.
        • Shahla J.
        • Lewis B.S.
        Relation between obesity and severity of coronary artery disease in patients undergoing coronary angiography.
        Am J Cardiol. 2006; 97: 1277-1280
        • Das S.R.
        • Alexander K.P.
        • Chen A.Y.
        • et al.
        Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-segment elevation myocardial infarction: results from the NCDR (National Cardiovascular Data Registry).
        J Am Coll Cardiol. 2011; 58: 2642-2650
        • Diercks D.B.
        • Roe M.T.
        • Mulgund J.
        • et al.
        The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative.
        Am Heart J. 2006; 152: 140-148
        • Zeller M.
        • Steg P.G.
        • Ravisy J.
        • et al.
        Relation between body mass index, waist circumference, and death after acute myocardial infarction.
        Circulation. 2008; 118: 482-490
        • Kaplan R.C.
        • Heckbert S.R.
        • Furberg C.D.
        • Psaty B.M.
        Predictors of subsequent coronary events, stroke, and death among survivors of first hospitalized myocardial infarction.
        J Clin Epidemiol. 2002; 55: 654-664
        • Rea T.D.
        • Heckbert S.R.
        • Kaplan R.C.
        • et al.
        Body mass index and the risk of recurrent coronary events following acute myocardial infarction.
        Am J Cardiol. 2001; 88: 467-472
        • O'Connor N.J.
        • Morton J.R.
        • Birkmeyer J.D.
        • Olmstead E.M.
        • O'Connor G.T.
        Effect of coronary artery diameter in patients undergoing coronary bypass surgery. Northern New England Cardiovascular Disease Study Group.
        Circulation. 1996; 93: 652-655
        • Uretsky S.
        • Messerli F.H.
        • Bangalore S.
        • et al.
        Obesity paradox in patients with hypertension and coronary artery disease.
        Am J Med. 2007; 120: 863-870
        • Carr M.E.
        Diabetes mellitus: a hypercoagulable state.
        J Diabetes Complications. 2001; 15: 44-54
        • De Pergola G.
        • Pannacciulli N.
        Coagulation and fibrinolysis abnormalities in obesity.
        J Endocrinol Invest. 2002; 25: 899-904
        • Klein S.
        • Allison D.B.
        • Heymsfield S.B.
        • et al.
        • Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; American Society for Nutrition; American Diabetes Association
        Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association.
        Am J Clin Nutr. 2007; 85: 1197-1202
        • Després J.P.
        • Lemieux I.
        Abdominal obesity and metabolic syndrome.
        Nature. 2006; 444: 881-887
        • Romero-Corral A.
        • Somers V.K.
        • Sierra-Johnson J.
        • et al.
        Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease.
        Eur Heart J. 2007; 28: 2087-2093
        • Hu G.
        • Tuomilehto J.
        • Silventoinen K.
        • Barengo N.
        • Jousilahti P.
        Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women.
        Eur Heart J. 2004; 25: 2212-2219
        • See R.
        • Abdullah S.M.
        • McGuire D.K.
        • et al.
        The association of differing measures of overweight and obesity with prevalent atherosclerosis: the Dallas Heart Study.
        J Am Coll Cardiol. 2007; 50: 752-759
        • Nasir K.
        • Campbell C.Y.
        • Santos R.D.
        • et al.
        The association of subclinical coronary atherosclerosis with abdominal and total obesity in asymptomatic men.
        Prev Cardiol. 2005; 8: 143-148
        • Romero-Corral A.
        • Montori V.M.
        • Somers V.K.
        • et al.
        Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies.
        Lancet. 2006; 368: 666-678
        • Lauretani F.
        • Russo C.R.
        • Bandinelli S.
        • et al.
        Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia.
        J Appl Physiol (1985). 2003; 95: 1851-1860
        • Roubenoff R.
        Sarcopenia and its implications for the elderly.
        Eur J Clin Nutr. 2000; 54: S40-S47
        • Artero E.G.
        • Lee D.C.
        • Lavie C.J.
        • et al.
        Effects of muscular strength on cardiovascular risk factors and prognosis.
        J Cardiopulm Rehabil Prev. 2012; 32: 351-358
        • Romero-Corral A.
        • Somers V.K.
        • Sierra-Johnson J.
        • et al.
        Accuracy of body mass index in diagnosing obesity in the adult general population.
        Int J Obes (Lond). 2008; 32: 959-966
        • Lavie C.J.
        • De Schutter A.
        • Patel D.A.
        • Romero-Corral A.
        • Artham S.M.
        • Milani R.V.
        Body composition and survival in stable coronary heart disease: impact of lean mass index and body fat in the “obesity paradox”.
        J Am Coll Cardiol. 2012; 60: 1374-1380
        • McAuley P.A.
        • Artero E.G.
        • Sui X.
        • et al.
        The obesity paradox, cardiorespiratory fitness, and coronary heart disease.
        Mayo Clin Proc. 2012; 87: 443-451
        • Lavie C.J.
        • Milani R.V.
        • Artham S.M.
        • Patel D.A.
        • Ventura H.O.
        The obesity paradox, weight loss, and coronary disease.
        Am J Med. 2009; 122: 1106-1114
        • Oreopoulos A.
        • Padwal R.
        • Norris C.M.
        • Mullen J.C.
        • Pretorius V.
        • Kalantar-Zadeh K.
        Effect of obesity on short- and long-term mortality postcoronary revascularization: a meta-analysis.
        Obesity (Silver Spring). 2008; 16: 442-450
        • Yancy Jr., W.S.
        • Olsen M.K.
        • Curtis L.H.
        • Schulman K.A.
        • Cuffe M.S.
        • Oddone E.Z.
        Variations in coronary procedure utilization depending on body mass index.
        Arch Intern Med. 2005; 165: 1381-1387
        • Buschur M.E.
        • Smith D.
        • Share D.
        • et al.
        The burgeoning epidemic of morbid obesity in patients undergoing percutaneous coronary intervention: insight from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
        J Am Coll Cardiol. 2013; 62: 685-691
        • Payvar S.
        • Kim S.
        • Rao S.V.
        • et al.
        In-hospital outcomes of percutaneous coronary interventions in extremely obese and normal-weight patients.
        J Am Coll Cardiol. 2013; 62: 692-696
        • Lavie C.J.
        • Milani R.V.
        • Ventura H.O.
        • Romero-Corral A.
        Body composition and heart failure prevalence and prognosis: getting to the fat of the matter in the “obesity paradox.”.
        Mayo Clin Proc. 2010; 85: 605-608
        • McAuley P.A.
        • Kokkinos P.F.
        • Oliveira R.B.
        • Emerson B.T.
        • Myers J.N.
        Obesity paradox and cardiorespiratory fitness in 12,417 male veterans aged 40 to 70 years.
        Mayo Clin Proc. 2010; 85: 115-121
        • Lavie C.J.
        • De Schutter A.
        • Patel D.
        • Artham S.M.
        • Milani R.V.
        Body composition and coronary heart disease mortality: an obesity or a lean paradox?.
        Mayo Clin Proc. 2011; 86: 857-864
        • Goel K.
        • Thomas R.J.
        • Squires R.W.
        • et al.
        Combined effect of cardiorespiratory fitness and adiposity on mortality in patients with coronary artery disease.
        Am Heart J. 2011; 161: 590-597
        • Galal W.
        • van Gestel Y.R.
        • Hoeks S.E.
        • et al.
        The obesity paradox in patients with peripheral arterial disease.
        Chest. 2008; 134: 925-930
        • Lavie C.J.
        • Ventura H.O.
        • Milani R.V.
        The “obesity paradox”: is smoking/lung disease the explanation?.
        Chest. 2008; 134: 896-898